Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Ryan Ungaro and Jean-Frederic Colombel.
Ryan Ungaro
Connection Strength
2.906
Jean-Frederic Colombel
  1. COVID-19 and Inflammatory Bowel Disease: Lessons Learned, Practical Recommendations, and Unanswered Questions. Gastroenterology. 2021 04; 160(5):1447-1451.
    View in: PubMed
    Score: 0.921
  2. New Gastrointestinal Symptoms Are Common in Inflammatory Bowel Disease Patients With COVID-19: Data From an International Registry. Inflamm Bowel Dis. 2022 02 01; 28(2):314-317.
    View in: PubMed
    Score: 0.248
  3. The Impact of Vedolizumab on COVID-19 Outcomes Among Adult IBD Patients in the SECURE-IBD Registry. J Crohns Colitis. 2021 Nov 08; 15(11):1877-1884.
    View in: PubMed
    Score: 0.244
  4. Autoimmune and Chronic Inflammatory Disease Patients with COVID-19. ACR Open Rheumatol. 2021 Feb; 3(2):111-115.
    View in: PubMed
    Score: 0.232
  5. Effect of IBD medications on COVID-19 outcomes: results from an international registry. Gut. 2021 04; 70(4):725-732.
    View in: PubMed
    Score: 0.227
  6. What Should Gastroenterologists and Patients Know About COVID-19? Clin Gastroenterol Hepatol. 2020 06; 18(7):1409-1411.
    View in: PubMed
    Score: 0.218
  7. Clinical updates on perianal fistulas in Crohn's disease. Expert Rev Gastroenterol Hepatol. 2018 Jun; 12(6):597-605.
    View in: PubMed
    Score: 0.193
  8. Presence of Comorbidities Associated with Severe Coronavirus Infection in Patients with Inflammatory Bowel Disease. Dig Dis Sci. 2021 Jun 28.
    View in: PubMed
    Score: 0.060
  9. COVID-19 Outcomes Among Racial and Ethnic Minority Individuals With Inflammatory Bowel Disease in the United States. Clin Gastroenterol Hepatol. 2021 10; 19(10):2210-2213.e3.
    View in: PubMed
    Score: 0.059
  10. Physician Practice Patterns in Holding Inflammatory Bowel Disease Medications due to COVID-19, in the SECURE-IBD Registry. J Crohns Colitis. 2021 May 04; 15(5):860-863.
    View in: PubMed
    Score: 0.059
  11. Characteristics and Outcomes of IBD Patients with COVID-19 on Tofacitinib Therapy in the SECURE-IBD Registry. Inflamm Bowel Dis. 2021 03 15; 27(4):585-589.
    View in: PubMed
    Score: 0.058
  12. Reply. Gastroenterology. 2021 04; 160(5):1886-1887.
    View in: PubMed
    Score: 0.058
  13. Data Visualization in the Era of COVID-19: An Interactive Map of the SECURE-IBD Registry. Am J Gastroenterol. 2020 11; 115(11):1923-1924.
    View in: PubMed
    Score: 0.057
  14. Benign Evolution of SARS-Cov2 Infections in Children With Inflammatory Bowel Disease: Results From Two International Databases. Clin Gastroenterol Hepatol. 2021 02; 19(2):394-396.e5.
    View in: PubMed
    Score: 0.057
  15. IBD in the COVID-19 era: the value of international collaboration. Lancet Gastroenterol Hepatol. 2020 10; 5(10):887-888.
    View in: PubMed
    Score: 0.057
  16. Intestinal Inflammation Modulates the Expression of ACE2 and TMPRSS2 and Potentially Overlaps With the Pathogenesis of SARS-CoV-2-related Disease. Gastroenterology. 2021 01; 160(1):287-301.e20.
    View in: PubMed
    Score: 0.057
  17. Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry. Gastroenterology. 2020 08; 159(2):481-491.e3.
    View in: PubMed
    Score: 0.055
  18. Proximal Disease Extension in Patients With Limited Ulcerative Colitis: A Danish Population-based Inception Cohort. J Crohns Colitis. 2017 Oct 01; 11(10):1200-1204.
    View in: PubMed
    Score: 0.046
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.